Search Results

There are 135678 results for: content related to: The antimicrobial peptide LL -37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils – implications for asthma

  1. Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M


    Volume 67, Issue 6, June 2012, Pages: 804–812, N. Kanda, C. S. Hau, Y. Tada, S. Sato and S. Watanabe

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1398-9995.2012.02824.x

  2. Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory epithelium inflammation in a mouse model

    International Forum of Allergy & Rhinology

    Volume 5, Issue 12, December 2015, Pages: 1141–1150, Jeremiah A. Alt, Xuan Qin, Abigail Pulsipher, Quinn Orb, Richard R. Orlandi, Jianxing Zhang, Austin Schults, Wanjian Jia, Angela P. Presson, Glenn D. Prestwich and Siam Oottamasathien

    Version of Record online : 8 SEP 2015, DOI: 10.1002/alr.21634

  3. You have free access to this content
    Extracellular DNA traps in allergic, infectious, and autoimmune diseases


    Volume 68, Issue 4, April 2013, Pages: 409–416, D. Simon, H.-U. Simon and S. Yousefi

    Version of Record online : 15 FEB 2013, DOI: 10.1111/all.12111

  4. You have free access to this content
    Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion

    International Journal of Cancer

    Volume 122, Issue 5, 1 March 2008, Pages: 1030–1039, Seth B. Coffelt, Ruth S. Waterman, Luisa Florez, Kerstin Höner zu Bentrup, Kevin J. Zwezdaryk, Suzanne L. Tomchuck, Heather L. LaMarca, Elizabeth S. Danka, Cindy A. Morris and Aline B. Scandurro

    Version of Record online : 24 OCT 2007, DOI: 10.1002/ijc.23186

  5. You have free access to this content
    Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications

    International Journal of Cancer

    Volume 127, Issue 8, 15 October 2010, Pages: 1741–1747, William K.K. Wu, Guangshun Wang, Seth B. Coffelt, Aline M. Betancourt, Chung W. Lee, Daiming Fan, Kaichun Wu, Jun Yu, Joseph J.Y. Sung and Chi H. Cho

    Version of Record online : 2 JUN 2010, DOI: 10.1002/ijc.25489

  6. Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases


    Volume 70, Issue 2, February 2015, Pages: 161–170, A. Gela, G. Kasetty, S. Jovic, M. Ekoff, G. Nilsson, M. Mörgelin, S. Kjellström, J. E. Pease, A. Schmidtchen and A. Egesten

    Version of Record online : 13 JAN 2015, DOI: 10.1111/all.12542

  7. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation


    Volume 70, Issue 4, April 2015, Pages: 443–452, D. Simon, S. Radonjic-Hösli, A. Straumann, S. Yousefi and H.-U. Simon

    Version of Record online : 26 JAN 2015, DOI: 10.1111/all.12570

  8. You have free access to this content
    Unique features of human cathelicidin LL-37


    Volume 41, Issue 5, September/October 2015, Pages: 289–300, Katarzyna Bandurska, Agnieszka Berdowska, Renata Barczyńska-Felusiak and Piotr Krupa

    Version of Record online : 5 OCT 2015, DOI: 10.1002/biof.1225

  9. Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells from atopic eczema patients and healthy individuals


    Volume 61, Issue 4, April 2006, Pages: 422–430, B. Agerberth, E. Buentke, P. Bergman, H. Eshaghi, S. Gabrielsson, G. H. Gudmundsson and A. Scheynius

    Version of Record online : 27 OCT 2005, DOI: 10.1111/j.1398-9995.2005.00952.x

  10. You have free access to this content
    Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease

    Clinical & Experimental Immunology

    Volume 191, Issue 1, January 2018, Pages: 96–106, S. Kusaka, A. Nishida, K. Takahashi, S. Bamba, H. Yasui, M. Kawahara, O. Inatomi, M. Sugimoto and A. Andoh

    Version of Record online : 28 SEP 2017, DOI: 10.1111/cei.13047

  11. You have free access to this content
    Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils

    European Journal of Immunology

    Volume 39, Issue 11, November 2009, Pages: 3181–3194, Zhifang Zhang, Gregory Cherryholmes, Frances Chang, David M. Rose, Ingrid Schraufstatter and John E. Shively

    Version of Record online : 11 SEP 2009, DOI: 10.1002/eji.200939496

  12. You have free access to this content
    Update in clinical allergy and immunology


    Volume 67, Issue 12, December 2012, Pages: 1491–1500, S. von Gunten, B. J. Marsland, C. von Garnier and D. Simon

    Version of Record online : 30 OCT 2012, DOI: 10.1111/all.12067

  13. Antimicrobial peptide hCAP-18/LL-37 protein and mRNA expressions in different periodontal diseases

    Oral Diseases

    Volume 17, Issue 1, January 2011, Pages: 60–67, O Türkoğlu, G Kandiloğlu, A Berdeli, G Emingil and G Atilla

    Version of Record online : 20 JUL 2010, DOI: 10.1111/j.1601-0825.2010.01704.x

  14. You have full text access to this OnlineOpen article
    Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages

    Journal of Leukocyte Biology

    Volume 86, Issue 4, October 2009, Pages: 891–902, Hsin-Ni Li, Peter G. Barlow, Johan Bylund, Annie Mackellar, Åse Björstad, James Conlon, Pieter S. Hiemstra, Chris Haslett, Mohini Gray, A. John Simpson, Adriano G. Rossi and Donald J. Davidson

    Version of Record online : 6 JUL 2009, DOI: 10.1189/jlb.0209050

  15. The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma

    British Journal of Dermatology

    Volume 163, Issue 5, November 2010, Pages: 959–967, J.E. Kim, H.J. Kim, J.M. Choi, K.H. Lee, T.Y. Kim, B.K. Cho, J.Y. Jung, K.Y. Chung, D. Cho and H.J. Park

    Version of Record online : 28 JUL 2010, DOI: 10.1111/j.1365-2133.2010.09957.x

  16. Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial

    Wound Repair and Regeneration

    Volume 22, Issue 5, September-October 2014, Pages: 613–621, Alvar Grönberg, Margit Mahlapuu, Mona Ståhle, Caroline Whately-Smith and Ola Rollman

    Version of Record online : 20 OCT 2014, DOI: 10.1111/wrr.12211

  17. The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells

    Journal of Cellular Physiology

    Volume 223, Issue 1, April 2010, Pages: 178–186, William Ka Kei Wu, Joseph Jao Yiu Sung, Ka Fai To, Le Yu, Hai Tao Li, Zhi Jie Li, Kin Man Chu, Jun Yu and Chi Hin Cho

    Version of Record online : 6 JAN 2010, DOI: 10.1002/jcp.22026

  18. You have free access to this content
    Antimicrobial peptide LL-37 promotes antigen-specific immune responses in mice by enhancing Th17-skewed mucosal and systemic immunities

    European Journal of Immunology

    Volume 45, Issue 5, May 2015, Pages: 1402–1413, Sae-Hae Kim, In-Young Yang, Ju Kim, Kyung-Yeol Lee and Yong-Suk Jang

    Version of Record online : 17 APR 2015, DOI: 10.1002/eji.201444988

  19. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium

    Oral Microbiology and Immunology

    Volume 15, Issue 4, August 2000, Pages: 226–231, D. Tanaka, K. T. Miyasaki and R. I. Lehrer

    Version of Record online : 25 DEC 2001, DOI: 10.1034/j.1399-302x.2000.150403.x

  20. You have free access to this content
    Meningococcal resistance to antimicrobial peptides is mediated by bacterial adhesion and host cell RhoA and Cdc42 signalling

    Cellular Microbiology

    Volume 15, Issue 11, November 2013, Pages: 1938–1954, Miriam Geörg, Lisa Maudsdotter, Raquel Tavares and Ann-Beth Jonsson

    Version of Record online : 30 JUL 2013, DOI: 10.1111/cmi.12163